3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trials

Lambert-Eaton Myasthenic Syndrome

(2018) Vita G. Kesner et al.   NEUROLOGIC CLINICS

Amifampridine phosphate (Firdapse®) is effective and safe in a phase 3 clinical trial in LEMS

(2016) Shin J Oh et al.   MUSCLE & NERVE

Voltage gated calcium channel antibody-related neurological diseases

(2015) Can Ebru Bekircan-Kurt   World Journal of Clinical Cases

Long-Term Follow-Up in Infantile-Onset Lambert-Eaton Myasthenic Syndrome

(2013) S. Portaro et al.   JOURNAL OF CHILD NEUROLOGY

Treatment in Lambert-Eaton myasthenic syndrome

(2012) Paul Maddison   Annals of the New York Academy of Sciences

Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: Results of a patient interview survey in Germany

(2012) Lutz Harms et al.   JOURNAL OF MEDICAL ECONOMICS

Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies

(2011) Maarten J Titulaer et al.   LANCET NEUROLOGY

Efficacy of 3,4-Diaminopyridine and Pyridostigmine in the Treatment of Lambert–Eaton Myasthenic Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

(2009) PW Wirtz et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS

(2009) Shin J. Oh et al.   MUSCLE & NERVE

Lambert-Eaton Myasthenic Syndrome

(2008) Maarten J. Titulaer et al.   Annals of the New York Academy of Sciences